Journal for ImmunoTherapy of Cancer (Nov 2023)

1071 Characterization of a tumor-targeting and activatable T-MASK platform to enhance tumor accumulation and tolerability of potent immune modulators

Rosemina Merchant,
Fahar Merchant,
Minh D To,
Aanchal Sharma

Affiliations

Rosemina Merchant: Medicenna Therapeutics, Toronto, ON, Canada
Fahar Merchant: Medicenna Therapeutics, Toronto, ON, Canada
Minh D To: Medicenna Therapeutics, Toronto, ON, Canada
Aanchal Sharma: Medicenna Therapeutics, Toronto, ON, Canada

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.1071
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal